The results of this pharmacological therapy [125] and other cell therapy [123,124] studies in the apoE-/- mouse supports ongoing studies in our laboratory, in which both therapies are associated with the purpose to obtain a better improvement of endothelial function in this murine model of hypercholesterolemia and atherosclerosis. The gene discussed is APOE; the disease is familial hypercholesterolemia.